SARASOTA, Fla., April 23, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing novel intranasal therapies for concussion and brain-related conditions ...

Oragenics (NYSE American: OGEN) a biotechnology company developing intranasal therapies for brain-related disorders, announced it has received approv ...

In response to the ongoing conflict with Hamas and Hezbollah, Ogen, a leading nonprofit social lending organization, has introduced a new initiative called "Ogen for the Future" to support ...

Oragenics (NYSE American: OGEN) will host a management update webinar on Tuesday, May 20, 2025, at 4:00 p.m. ET to discuss the unmet medical need in ...

Oragenics Inc (NASDAQ:OGEN) shares are trading lower by 45.5% to $0.58 during Wednesday’s session after the company announced ...

SARASOTA, Fla. (AP) — SARASOTA, Fla. (AP) — Oragenics Inc. (OGEN) on Friday reported a loss of $2.2 million in its first quarter. On a per-share basis, the Sarasota, Florida-based company said it had ...